-+ 0.00%
-+ 0.00%
-+ 0.00%

Fate Therapeutics grants 67,300 RSUs to two new hires under inducement plan

PUBT·06/02/2026 20:05:24
Listen to the news
Fate Therapeutics grants 67,300 RSUs to two new hires under inducement plan
  • Fate Therapeutics granted RSUs covering 67,300 common shares to two newly hired non-executive employees on June 1, 2026.
  • Awards were issued under the Amended and Restated Inducement Equity Plan.
  • RSUs vest over four years, with 25% vesting on each anniversary of the grant date, subject to continued employment.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Fate Therapeutics Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202606021605PRIMZONEFULLFEED9730636) on June 02, 2026, and is solely responsible for the information contained therein.